A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.

Bovine respiratory syncytial virus (RSV) has substantial morbidity in young calves, and closely parallels human RSV in infants. We performed a randomized controlled trial in five to six-week-old Holstein calves (Bos taurus). comparing fusion protein inhibitor (FPI) and non-steroidal anti-inflammator...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Francisco R Carvallo Chaigneau, Paul Walsh, Maxim Lebedev, Victoria Mutua, Heather McEligot, Heejung Bang, Laurel J Gershwin
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8c06f7c4ad7540dd864dee34aabebd07
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8c06f7c4ad7540dd864dee34aabebd07
record_format dspace
spelling oai:doaj.org-article:8c06f7c4ad7540dd864dee34aabebd072021-12-02T20:10:51ZA randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.1932-620310.1371/journal.pone.0252455https://doaj.org/article/8c06f7c4ad7540dd864dee34aabebd072021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0252455https://doaj.org/toc/1932-6203Bovine respiratory syncytial virus (RSV) has substantial morbidity in young calves, and closely parallels human RSV in infants. We performed a randomized controlled trial in five to six-week-old Holstein calves (Bos taurus). comparing fusion protein inhibitor (FPI) and non-steroidal anti-inflammatory drug (NSAID) singly and in combination at three and five days after experimental BRSV infection. Thirty-six calves received one of six treatments; Ibuprofen started on day 3, Ibuprofen started on day 5, FPI started on day 5, FPI and Ibuprofen started on day 3, FPI and Ibuprofen started on day 5, or placebo. We have previously reported significant clinical benefits when combined FPI and NSAID treatment was started at three and five days after bovine RSV infection. Necropsy was performed on Day 10 following infection and hematoxylin and eosin staining was performed on sections from each lobe. Histology was described using a four-point scale. We performed canonical discrimination analysis (CDA) to determine the structural level where differences between treatments occurred and mixed effects regression to estimate effect sizes. Separation from placebo was maximal for dual therapy at the levels of the alveolus, septum, and bronchus in CDA. We found that the clinical benefits of combined FPI and NSAID treatment of BRSV extend at least partially from histopathological changes in the lung when treatment was started three days after infection. We found decreased lung injury when ibuprofen was started as monotherapy on day 3, but not day 5 following infection. Combined therapy with both an FPI and ibuprofen was always better than ibuprofen alone. We did not prove that the clinical benefits seen starting FPI and ibuprofen five days after infection can be solely explained by histopathological differences as identified on H&E staining.Francisco R Carvallo ChaigneauPaul WalshMaxim LebedevVictoria MutuaHeather McEligotHeejung BangLaurel J GershwinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0252455 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Francisco R Carvallo Chaigneau
Paul Walsh
Maxim Lebedev
Victoria Mutua
Heather McEligot
Heejung Bang
Laurel J Gershwin
A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
description Bovine respiratory syncytial virus (RSV) has substantial morbidity in young calves, and closely parallels human RSV in infants. We performed a randomized controlled trial in five to six-week-old Holstein calves (Bos taurus). comparing fusion protein inhibitor (FPI) and non-steroidal anti-inflammatory drug (NSAID) singly and in combination at three and five days after experimental BRSV infection. Thirty-six calves received one of six treatments; Ibuprofen started on day 3, Ibuprofen started on day 5, FPI started on day 5, FPI and Ibuprofen started on day 3, FPI and Ibuprofen started on day 5, or placebo. We have previously reported significant clinical benefits when combined FPI and NSAID treatment was started at three and five days after bovine RSV infection. Necropsy was performed on Day 10 following infection and hematoxylin and eosin staining was performed on sections from each lobe. Histology was described using a four-point scale. We performed canonical discrimination analysis (CDA) to determine the structural level where differences between treatments occurred and mixed effects regression to estimate effect sizes. Separation from placebo was maximal for dual therapy at the levels of the alveolus, septum, and bronchus in CDA. We found that the clinical benefits of combined FPI and NSAID treatment of BRSV extend at least partially from histopathological changes in the lung when treatment was started three days after infection. We found decreased lung injury when ibuprofen was started as monotherapy on day 3, but not day 5 following infection. Combined therapy with both an FPI and ibuprofen was always better than ibuprofen alone. We did not prove that the clinical benefits seen starting FPI and ibuprofen five days after infection can be solely explained by histopathological differences as identified on H&E staining.
format article
author Francisco R Carvallo Chaigneau
Paul Walsh
Maxim Lebedev
Victoria Mutua
Heather McEligot
Heejung Bang
Laurel J Gershwin
author_facet Francisco R Carvallo Chaigneau
Paul Walsh
Maxim Lebedev
Victoria Mutua
Heather McEligot
Heejung Bang
Laurel J Gershwin
author_sort Francisco R Carvallo Chaigneau
title A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
title_short A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
title_full A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
title_fullStr A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
title_full_unstemmed A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
title_sort randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/8c06f7c4ad7540dd864dee34aabebd07
work_keys_str_mv AT franciscorcarvallochaigneau arandomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT paulwalsh arandomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT maximlebedev arandomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT victoriamutua arandomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT heathermceligot arandomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT heejungbang arandomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT laureljgershwin arandomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT franciscorcarvallochaigneau randomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT paulwalsh randomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT maximlebedev randomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT victoriamutua randomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT heathermceligot randomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT heejungbang randomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
AT laureljgershwin randomizedcontrolledtrialcomparingnonsteroidalantiinflammatoryandfusionproteininhibitorssinglyandincombinationonthehistopathologyofbovinerespiratorysyncytialvirusinfection
_version_ 1718374958785101824